| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 12/21/2007 | CA2655286A1 Therapeutic or prophylactic agent for allergic dermatitis |
| 12/21/2007 | CA2653654A1 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use |
| 12/21/2007 | CA2653157A1 Induction of tolerance to egg proteins |
| 12/21/2007 | CA2650666A1 Substituted cyanopyridines as protein kinase inhibitors |
| 12/20/2007 | US20070293570 Pharmaceutical uses for alpha2delta ligands |
| 12/20/2007 | US20070293560 Compounds and compositions |
| 12/20/2007 | US20070293555 4-methoxy-benzoic acid 1-imidazol-1-yl methyl-2-(4-fluorophenoxy)-ethyl ester; N-[(1-imidazol-1-yl methyl)-2-phenoxy-ethyl]-4-iodo-benzamide; cancer, inflammation, septic shock, infertility, preterm labor, pain, or an ischemia |
| 12/20/2007 | US20070293554 Non-peptide inhibition of T-lymphocyte activation and therapies related thereto |
| 12/20/2007 | US20070293548 Inhibitors of semicarbazide-sensitive amine oxidase (SSAO) and VAP-1 mediated adhesion useful for treatment and prevention of diseases |
| 12/20/2007 | US20070293541 CB1 cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders |
| 12/20/2007 | US20070293524 Salts, hydrates, solvatesand/or N-oxides; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors; inhibiting an Fc receptor signal transduction cascade |
| 12/20/2007 | US20070293523 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents |
| 12/20/2007 | US20070293522 2,4-pyrimidinediamine compounds and their uses |
| 12/20/2007 | US20070293521 inhibitors of immunoglobulin E or G receptor signaling cascades; Syk kinase inhibitors; use as antiallergic, antiinflammatory agents |
| 12/20/2007 | US20070293520 2,4-pyrimidinediamine compounds and their uses |
| 12/20/2007 | US20070293517 Derivatives Of Chemotherapeutic Agents With A Formaldehyde Releasing Moiety |
| 12/20/2007 | US20070293499 Intracellular Kinase Inhibitors |
| 12/20/2007 | US20070293488 tyrosine kinase inhibitors such as 1-(2-fluoro-5-trifluoromethylphenyl)-3-[4-(5-oxo-5,8-dihydropyrido[2,3-d]pyrimidin-4-ylamino)phenyl]urea, used as antitumor or anticarcinogenic agents or for the treatment of psoriasis, arthritis, retinopathy or dermatitis |
| 12/20/2007 | US20070293484 Thiophene Heteroaryl Amines |
| 12/20/2007 | US20070293464 Substituted Pyrimidine Compositions and Methods of Use |
| 12/20/2007 | US20070293454 Complex Containing Mequitazine, a Cyclodextrin and an Interaction Agent |
| 12/20/2007 | US20070293424 Antitumoral and Antiviral Peptides |
| 12/20/2007 | US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease |
| 12/20/2007 | US20070292904 Ephrin and EPH receptor mediated immune modulation |
| 12/20/2007 | US20070292533 Copper lowering treatment of autoimmune diseases |
| 12/20/2007 | US20070292455 chimeric dna viruses; disrupted open reading frame; for treating or preventing viral infections; immunogens |
| 12/20/2007 | US20070292452 Vaccine Compositions Which Are Obtained From Streptomyces |
| 12/20/2007 | US20070292440 CD154 blockade therapy for pancreatic islet tissue transplantation |
| 12/20/2007 | US20070292439 B cell-related cancers and solid tumors, and diseases or disorders that have an autoimmune and/or inflammatory component, including organ and tissue transplant rejection |
| 12/20/2007 | US20070292436 Immunogenic proteoliposomes, and uses thereof |
| 12/20/2007 | US20070292432 Immunoglobulins |
| 12/20/2007 | US20070292430 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
| 12/20/2007 | US20070292424 Novel human eosinophil-derived basic protein |
| 12/20/2007 | US20070292422 Using CD70 specific immunoglobulins to prevent and treat cell proliferative disorders; immunosuppressant |
| 12/20/2007 | US20070292420 For diagnosing or treating rheumatoid arthritis, osteoarthritis, osteolysis, aseptic loosening of orthopedic implants, lupus, type 2 diabetes, COPD, and renal cell carcinoma |
| 12/20/2007 | US20070292417 Chimeric allgraft tolerance induction, monitoring and maintenance |
| 12/20/2007 | US20070292416 De-Immunized Anti-Cd3 Antibody |
| 12/20/2007 | US20070292414 Compositions enriched in neoplastic stem cells and methods comprising same |
| 12/20/2007 | US20070292347 Peptides Associated with Hla-Dr Mhc Clas II Molecules Involved in Autoimmune Diseases |
| 12/20/2007 | CA2602555A1 Composition and method for reducing inflammation |
| 12/19/2007 | EP1867718A2 Therapeutically useful synthetic oligonucleotides |
| 12/19/2007 | EP1867656A1 Compound having cyclic structure and use thereof |
| 12/19/2007 | EP1867336A2 Adminstration of an anti-endotoxin drug by intravenous infusion |
| 12/19/2007 | EP1866338A1 Antibodies against cd38 for treatment of multiple myeloma |
| 12/19/2007 | EP1866325A2 Novel crystalline pharmaceutical product |
| 12/19/2007 | EP1866311A2 Novel compounds |
| 12/19/2007 | EP1866286A1 Pyridine derivatives useful as inhibitors of pkc-theta |
| 12/19/2007 | EP1865985A2 Kim-1 antibodies for treatment of th2-mediated conditions |
| 12/19/2007 | EP1865950A1 Compounds useful as modulators of the proteasome activity |
| 12/19/2007 | EP1539713B1 Pyrimidine derivatives as modulators of chemokine receptor activity |
| 12/19/2007 | EP1490062B1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/19/2007 | EP1434567B1 Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid |
| 12/19/2007 | EP1406872B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 12/19/2007 | EP1370521B1 Formanilide derivatives as beta2-adrenoreceptor agonists |
| 12/19/2007 | EP1326856B1 Pyridine derivatives with ikb-kinase (ikk-beta) inhibiting activity |
| 12/19/2007 | EP1305435B1 Use of herpes simplex virus glycoprotein d to suppress immune responses |
| 12/19/2007 | EP1295870B1 Suplatast tosilate crystals |
| 12/19/2007 | EP1292596B1 1,3,8-triaza-spiro¬4,5 decan-4-one derivatives as neurokinin receptor antagonists |
| 12/19/2007 | EP1194166B1 Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 12/19/2007 | EP1091757B1 Alpha emitting constructs and uses thereof |
| 12/19/2007 | EP0772689B1 Retroviral vectors having a reduced recombination rate |
| 12/19/2007 | CN101090715A Dendritic cell infiltrativity activating composition and immune activator |
| 12/19/2007 | CN101089186A Expression carrier for human L-type complement agglutinant fibre gelled protein and construction and application |
| 12/19/2007 | CN101089180A Recombination LFA3 gene, and its mixed gene and product |
| 12/19/2007 | CN101089179A Hog B-lymphocyte irritation factor CDNA and its clone method and recombination application |
| 12/19/2007 | CN101089004A New type of phosphonate-nucleotide compound |
| 12/19/2007 | CN101088560A Antigenic composite, multi-clone antibody prepared by it and its application |
| 12/19/2007 | CN101088555A Medicine prepn for inhibiting tumor angiogenesis and cancer cell and enhancing immunity |
| 12/19/2007 | CN101088540A Chinese medicine for treating senility and raising immunity of middle aged people and old people |
| 12/19/2007 | CN101088535A Chinese medicine for treating tumor |
| 12/19/2007 | CN101088521A Astragalus medicine prepn and its prepn process |
| 12/19/2007 | CN101088513A 生命技术及其应用 Life Technologies and Applications |
| 12/19/2007 | CN101088406A Health food for strengthening immunity and its production process |
| 12/19/2007 | CN100355876C Basidiomycetes, basidiomycetes extract composition, and health foods and immunopotentiators |
| 12/19/2007 | CN100355786C Polyethylene glycol-modified thymus peptide 1 derivatives |
| 12/19/2007 | CN100355777C Hepatitis B virus pre-S mutain, and its preparing process and application |
| 12/19/2007 | CN100355753C Tropan derivatives useful in therapy, method for obtaining thereof and intermediate compounds |
| 12/19/2007 | CN100355751C 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders |
| 12/19/2007 | CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof |
| 12/19/2007 | CN100355728C Inhibitors of dipeptidyl peptidase IV |
| 12/18/2007 | US7309800 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 12/18/2007 | US7309721 Aminoalkylphosphonates and related compounds as Edg receptor agonists |
| 12/18/2007 | US7309718 Leukotriene D4 and E4 antagonists; antiasthmatic, antiallergic and antiinflammatory agents; oral absorbability, sustained action; such as [3-[(E)-2-(6,7-difluoroquinolin-2-yl)ethenyl]-5H-dibenzo[a,d]cyclohepten-5-yl]oxyacetic acid |
| 12/18/2007 | US7309710 Crystals |
| 12/18/2007 | US7309703 Substituted pyrazoles useful for treating autoimmune diseases mediated by cathepsin S |
| 12/18/2007 | CA2462459C Copolymers for suppression of autoimmune diseases, and methods of use |
| 12/18/2007 | CA2249390C Peptides recognized by melanoma-specific a1-, a2- and a3-restricted cytotoxic lymphocytes, and uses therefor |
| 12/18/2007 | CA2233042C Specific binding members for human transforming growth factor beta; materials and methods |
| 12/13/2007 | WO2007143382A2 Oral liquid loratadine formulations and methods |
| 12/13/2007 | WO2007142392A1 Pharmaceutical composition comprising polysaccharides from angelica gigas nakai for activation of dendritic cells |
| 12/13/2007 | WO2007142325A1 Preventive or remedy for inflammatory disease |
| 12/13/2007 | WO2007142323A1 Novel indazole derivative having spiro ring structure in side chain |
| 12/13/2007 | WO2007142303A1 Method for controlling the amount of gene product, and agent for controlling the amount of gene product |
| 12/13/2007 | WO2007142300A1 Method of producing lymphocytes |
| 12/13/2007 | WO2007142253A1 2-cyanopyrrolidine derivative |
| 12/13/2007 | WO2007142096A1 Inhibitor of inducible nitric oxide synthase, beverage/food, and neutraceutical food |
| 12/13/2007 | WO2007141667A2 Immunosuppressive extract of cordyceps sinensis and uses thereof |
| 12/13/2007 | WO2007140987A1 Stable and bioavailable formulations and a novel form of desloratadine |
| 12/13/2007 | WO2007140618A1 Modified protein toxins targeting cytokine -receptor bearing cells and use thereof for treating disease |
| 12/13/2007 | US20070287970 Method for systemic drug delivery through the nail |